Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02758301 · ClinicalTrials.gov registry record
Reveal LINQ™ Heart Failure
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 112
- Enrollment target
NCT02758301 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 112 participants.
The verdict
NCT02758301 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
Study Summary
The purpose of the LINQ™ HF study is to characterize Reveal LINQ™ derived data from patients with heart failure by assessing the relationship between changes in LINQ™ derived data and other physiologic parameters with subsequent acute decompensated heart failure (ADHF) events.
Interventions
- DEVICE Reveal LINQ™ Insertable Cardiac Monitor (ICM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2016-06-08 |
| Est. Completion | 2018-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02758301
The ClinicalTrials.gov registry entry for NCT02758301 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reveal LINQ™ Insertable Cardiac Monitor (ICM) is the first listed.
NCT02758301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02758301 about?
NCT02758301 is a clinical study titled "Reveal LINQ™ Heart Failure". The purpose of the LINQ™ HF study is to characterize Reveal LINQ™ derived data from patients with heart failure by assessing the relationship between changes in LINQ™ derived data and other physiologic parameters with subsequent acute decompensated heart failure (ADHF) events.
What is the current status of trial NCT02758301?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2016-06-08. Estimated completion is 2018-12-04.
What interventions are being tested in trial NCT02758301?
The interventions under investigation include: Reveal LINQ™ Insertable Cardiac Monitor (ICM) (DEVICE).
Who is sponsoring clinical trial NCT02758301?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.